Suboxone
Description:
Patient information sheet on buprenorphine plus naloxone sublingual film
Source:
Reckitt Benckiser Pharmaceuticals
Description:
This document discusses the evidence for buprenorphine treatment of opioid dependent adolescents and young adults. It provides treatment recommendations, and highlights special issues that should be considered when treating this special population.
Source:
Physician Clinical Support System (PCSS)
Tags:
- General information - buprenorphine
- Induction and dosing
- Stabilization and maintenance
- Special populations
- Addiction
- Adolescents
- Comorbidities
- Dependence
- Detoxification
- Diagnosis
- Dosing
- Hepatitis
- Heroin
- HIV/AIDS
- Induction
- Maintenance
- Overdose
- Precautions
- Psychosocial
- Relapse
- Side effects
- Special populations
- Suboxone
- Withdrawal
- Treatment Algorithm
- Experienced prescriber
- Just became waivered
Description:
PCSS-B is a free mentoring service funded by SAMHSA and coordinated by ASAM. The PCSS-B can match you with a physician mentor from your local area with whom you can discuss practice and treatment issues with him/her.
Source:
Physician Clinical Support System (PCSS)
Tags:
Description:
This article provides guidance on the management and treatment of acute pain in patients receiving buprenorphine/naloxone.
Source:
Physician Clinical Support System (PCSS)
Tags:
- General information - buprenorphine
- Induction and dosing
- Stabilization and maintenance
- Special populations
- Logistics of buprenorphine treatment
- Addiction
- Dependence
- Discontinuation
- Dosing
- Induction
- Maintenance
- Methadone
- Pain
- Pharmacology
- Relapse
- Special populations
- Suboxone
- Withdrawal
- Treatment Algorithm
- Experienced prescriber
- Just became waivered
Description:
Buprenorphine tablets are approved for the treatment of opiate dependence. Buprenorphine treats opiate addiction by preventing symptoms of withdrawal from heroin and other opiates.
Source:
Food and Drug Administration (FDA)
Tags:
Description:
This 2009 article discusses a study of home induction for buprenorphine treatment; the results supported the hypothesis that home induction is a feasible and safe option.
Source:
J Gen Intern Med.
Description:
This journal article compares the effectiveness of detoxification vs. continuing buprenorphine-naloxone therapy for treating opioid-addicted adolescents. The study followed 152 patients between the ages of 15 and 21 who were randomly selected to receive either a 12-week buprenorphone-naloxone program, or a 14-day taper.
Source:
The Journal of the American Medical Association (JAMA) (2 votes)
Tags:
Description:
A study on the treatment of Chronic Pain Syndrome with Buprenorphine.
Source:
Washington Society for Addiction Medicine (2 votes)
Tags:
Description:
Highlights key points on treating pain in patients being maintained on Suboxone.
Source:
Suboxone Assisted Treatment/Medical Assisted Treatment of America (2 votes)
Tags:
Description:
Informative letter to physicians regarding pain management in patients being maintained on Suboxone. Offers strategies for circumventing the problem of buprenorphine blocking the analgesic effect of other opioids.
Source:
Reckitt Benckiser (2 votes)
Tags:
